AI + EXCLUSIVE DATA

AI analyzes funding data you can't access anywhere else

Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.

10-25 personalized leads daily • 92% average intent score • Smart feed technology

Start with:

✓Flexible Plans • $39/mo or $29/mo annual

✓AI + real-time funding intelligence

✓Never see duplicates in your feed

INDUSTRY FIRST

Inscripta announced it raised $4.4 Million in an initial filing from an offering of $4.4 Million

Jan 18, 2023•over 2 years ago

Amount Raised

$4.4 Million

Round Type

seed

BoulderBiotechnologyManufacturing

Company Information

Company

Inscripta

Location

Boulder, Colorado, United States

About

Inscripta® is a life science technology company committed to creating a cleaner, healthier, and more sustainable world through biomanufacturing. A global leader in genome engineering, our innovations are designed to unlock the full potential of the bioeconomy. We are committed to the continued development of critical technologies that enable scientists to bolster and expand domestic biomanufacturing, and spur new, safe, and secure biotech innovations. Inscripta supports customers around the world from facilities in Pleasanton and Burlingame, California. To learn more, visit Inscripta.com and follow @InscriptaInc.

Company News

(10 articles)

Tue, 06 Mar 2018 01:28:01 GMT

Inscripta - Crunchbase

Wed, 18 Jan 2023 08:00:00 GMT

INSCRIPTA® ACQUIRES INFINOME BIOSCIENCES AND SESTINA BIO TO ADVANCE SUSTAINABLE BIOMANUFACTURING - PR Newswire

Mon, 05 Apr 2021 07:00:00 GMT

Inscripta closes $150M VC round, scores first commercial buyer of CRISPR gene editing platform - Fierce Biotech

Mon, 20 Jun 2022 16:01:18 GMT

Inscripta Launches the World’s First Benchtop Platform for Digital Genome Engineering - SynBioBeta

Tue, 12 Oct 2021 07:00:00 GMT

Hunterian Medicine® Licenses Inscripta’s MAD7™ Nuclease to Advance Gene Editing Research and Development - Business Wire

Sat, 26 Nov 2022 08:00:00 GMT

How The Skincare Industry Is Turning to Gene Editing in a Race Against Time - Forbes

Mon, 05 Apr 2021 07:00:00 GMT

Inscripta Announces the First Commercial Shipment of Its Onyx™ Digital Genome Engineering Platform and Closes $150 Million in New Financing - Business Wire

Wed, 06 Oct 2021 07:00:00 GMT

Amyris Partners with Inscripta to Enhance Development of Sustainable Ingredients Using the Onyx™ Genome Engineering Platform - SynBioBeta

Wed, 05 Oct 2022 07:00:00 GMT

SESTINA BIO USES INSCRIPTA'S ONYX® PLATFORM TO DEVELOP MICROBIAL STRAIN READY FOR SCALE-UP IN LESS THAN 12 MONTHS - PR Newswire

Mon, 16 Jan 2023 08:00:00 GMT

Deep mutational scanning of essential bacterial proteins can guide antibiotic development - Nature

FundzWatch™ Score

Medium Activity